Treatment of Fibromyalgia with Neurostimulation: a Randomized, Double-Blinded, Sham-Controlled Trial
Arthritis & Rheumatology
Background/Purpose: NeuroPoint is a medical device designed to provide noninvasive brain stimulation using a proprietary approach to deliver very low energy levels to deep brain structures. NeuroPoint provides a therapy referred to as “reduced impedance noninvasive cortical electrostimulation” (RINCE). An initial feasibility study of 77 patients diagnosed with fibromyalgia (FM) was conducted between 2006 and 2008. The current pilot study was designed to further evaluate the safety and efficacy of RINCE therapy in the treatment of FM.
Copyright © 2014, John Wiley and Sons
Hargrove, Jeffrey; Gendreau, R. Michael; Deering, Donald; and Gendreau, Judith, "Treatment of Fibromyalgia with Neurostimulation: a Randomized, Double-Blinded, Sham-Controlled Trial" (2014). Mechanical Engineering Publications. 44.